Who Owns THNR?
Amplify Weight Loss Drug & Treatment ETF — Institutional Ownership & 13F Holdings
$24.52
+0.93 (+3.95%)
Market Cap
$3.2M
Shares Outstanding
130,020
Institutional Holders
4
Total Inst. Value
$1.4M
% of Float Held
—
QoQ Holder Change
—
Institutional data as of Q1 2025
Top 10 Institutional Holders(Q1 2025)
| # | Fund | Value | Shares |
|---|---|---|---|
| 1 | GTS SECURITIES LLC | $719K | 33,373 |
| 2 | JANE STREET GROUP, LLC | $536K | 24,891 |
| 3 | HARBOUR INVESTMENTS, INC. | $123K | 5,688 |
| 4 | UBS Group AG | $13K | 598 |
Biggest Buyers & Sellers This Quarter
Top Buyers
| Fund | Shares Added | Value |
|---|---|---|
| GTS SECURITIES LLC | +9K | $719K |
| JANE STREET GROUP, LLC | +1K | $536K |
| UBS Group AG | +152 | $13K |
Top Sellers
| Fund | Shares Removed | Value |
|---|---|---|
| HARBOUR INVESTMENTS, INC. | -1K | $123K |
Related Stocks
Frequently Asked Questions
How many institutional investors hold THNR?
As of Q1 2025, 4 institutional investors report holding THNR (Amplify Weight Loss Drug & Treatment ETF) in their 13F filings.
Which hedge fund owns the most THNR?
The largest institutional holder of THNR is GTS SECURITIES LLC with $719K in shares.
Are institutions buying or selling THNR?
This quarter, 0 institutions opened new positions in THNR and 1 closed their positions.
What is 13F institutional ownership?
SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.
How often is institutional ownership data updated?
13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.